Arcutis' approvals, growth, and strategic partnerships position it for cash flow breakeven by 2026. Read here for an analysis ...

Organogenesis' Q1 2025 earnings disappointed, with dominant Advanced Wound Care segment experiencing a sharp revenue decline ...

June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association is reinforcing how important everybody’s ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

On May 27, 2025, the Food and Drug Administration (FDA) released a new draft guidance, “Replacing Color Additives in Approved or Marketed ...

When I started my career in law enforcement, I took an oath to serve and protect my community. Now, as executive director of the Pennsylvania Chiefs of Police Association, I see that oath being lived ...

A Massachusetts man died from a benzodiazepine-like "designer drug" he purchased from an illicit online marketplace, where ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...